24 research outputs found

    Contribution of the nos-pdt Operon to Virulence Phenotypes in Methicillin-Sensitive Staphylococcus aureus

    Get PDF
    Nitric oxide (NO) is emerging as an important regulator of bacterial stress resistance, biofilm development, and virulence. One potential source of endogenous NO production in the pathogen Staphylococcus aureus is its NO-synthase (saNOS) enzyme, encoded by the nos gene. Although a role for saNOS in oxidative stress resistance, antibiotic resistance, and virulence has been recently-described, insights into the regulation of nos expression and saNOS enzyme activity remain elusive. To this end, transcriptional analysis of the nos gene in S. aureus strain UAMS-1 was performed, which revealed that nos expression increases during low-oxygen growth and is growth-phase dependent. Furthermore, nos is co-transcribed with a downstream gene, designated pdt, which encodes a prephenate dehydratase (PDT) enzyme involved in phenylalanine biosynthesis. Deletion of pdt significantly impaired the ability of UAMS-1 to grow in chemically-defined media lacking phenylalanine, confirming the function of this enzyme. Bioinformatics analysis revealed that the operon organization of nos-pdt appears to be unique to the staphylococci. As described for other S. aureus nos mutants, inactivation of nos in UAMS-1 conferred sensitivity to oxidative stress, while deletion of pdt did not affect this phenotype. The nos mutant also displayed reduced virulence in a murine sepsis infection model, and increased carotenoid pigmentation when cultured on agar plates, both previously-undescribed nos mutant phenotypes. Utilizing the fluorescent stain 4-Amino-5-Methylamino-2',7'-Difluorofluorescein (DAF-FM) diacetate, decreased levels of intracellular NO/reactive nitrogen species (RNS) were detected in the nos mutant on agar plates. These results reinforce the important role of saNOS in S. aureus physiology and virulence, and have identified an in vitro growth condition under which saNOS activity appears to be upregulated. However, the significance of the operon organization of nos-pdt and potential relationship between these two enzymes remains to be elucidated

    Virus-Bacteria Interactions: An Emerging Topic in Human Infection

    No full text
    Bacteria and viruses often occupy the same niches, however, interest in their potential collaboration in promoting wellness or disease states has only recently gained traction. While the interaction of some bacteria and viruses is well characterized (e.g., influenza virus), researchers are typically more interested in the location of the infection than the manner of cooperation. There are two overarching types of bacterial-virus disease causing interactions: direct interactions that in some way aid the viruses, and indirect interactions aiding bacteria. The virus-promoting direct interactions occur when the virus exploits a bacterial component to facilitate penetration into the host cell. Conversely, indirect interactions result in increased bacterial pathogenesis as a consequence of viral infection. Enteric viruses mainly utilize the direct pathway, while respiratory viruses largely affect bacteria in an indirect fashion. This review focuses on some key examples of how virus-bacteria interactions impact the infection process across the two organ systems, and provides evidence supporting this as an emerging theme in infectious disease

    Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens

    No full text
    Histo-blood group antigens (HBGAs) are commonly accepted as the cellular receptors for human norovirus. However, some human noroviruses have been found not to bind any HBGA ligand, suggesting potential additional co-factors. Some ligands have been found to bind noroviruses and have the potential to be additional cellular receptors/attachment factors for human norovirus or inhibitors of the HBGA interaction. The studies identifying these mostly characterize different chemical, human, food, or bacterial components and their effect on norovirus binding and infection, although the mechanism of interaction is unknown in many cases. This review seeks to supplement the already well-covered HBGA-norovirus literature by covering non-HBGA human norovirus ligands and inhibitors to provide investigators with a more comprehensive view of norovirus ligands

    Human norovirus binding to select bacteria representative of the human gut microbiota

    No full text
    <div><p>Recent reports describe the ability of select bacterial strains to bind human norovirus, although the specificity of such interactions is unknown. The purpose of this work was to determine if a select group of bacterial species representative of human gut microbiota bind to human norovirus, and if so, to characterize the intensity and location of that binding. The bacteria screened included naturally occurring strains isolated from human stool (<i>Klebsiella</i> spp., <i>Citrobacter</i> spp., <i>Bacillus</i> spp., <i>Enterococcus faecium</i> and <i>Hafnia alvei</i>) and select reference strains (<i>Staphylococcus aureus</i> and <i>Enterobacter cloacae</i>). Binding in PBS was evaluated to three human norovirus strains (GII.4 New Orleans 2009 and Sydney 2012, GI.6) and two surrogate viruses (Tulane virus and Turnip Crinkle Virus (TCV)) using a suspension assay format linked to RT-qPCR for quantification. The impact of different overnight culture media prior to washing on binding efficiency in PBS was also evaluated, and binding was visualized using transmission electron microscopy. All bacteria tested bound the representative human norovirus strains with high efficiency (<1 log<sub>10</sub> of input virus remained unbound or <10% unbound and >90% binding efficiency) (p>0.05); there was selective binding for Tulane virus and no binding observed for TCV. Binding efficiency was highest when bacteria were cultured in minimal media (<1 log<sub>10</sub> of input virus remained unbound, so >90% bound), but notably decreased when cultured in enriched media (1–3 log<sub>10</sub> unbound or 0.01 –<90% bound)) (p<0.05). The norovirus-bacteria binding occurred around the outer cell surfaces and pili structures, without apparent localization. The findings reported here further elucidate and inform the dynamics between human noroviruses and enteric bacteria with implications for norovirus pathogenesis.</p></div

    Human norovirus binding to select bacteria representative of the human gut microbiota - Fig 3

    No full text
    <p><b>Transmission electron microscopy (50,000x) photos of select bacteria to which GII.4 Sydney 2012 (A-C) and GII.4 Farmington Hills 2002 (D-F) VLPs are bound.</b> Bacteria-VLP interactions are shown as follows: (A) <i>E</i>. <i>cloacae</i>, (B) <i>S</i>. <i>aureus</i>, (C) <i>Bacillus</i> spp., (D) <i>E</i>. <i>faecium</i>, (E) <i>Citrobacter</i> spp., and (F) <i>H</i>. <i>alvei</i>. Representative VLPs are pointed out with the arrows, although additional VLPs are frequently also present in the image. Images shown are representative of multiple fields of view.</p

    Binding efficiency of the GII.4 Sydney 2012 when bacterial strains were grown in different media.

    No full text
    <p>The line indicates the total virus input. Data are expressed as mean log<sub>10</sub> concentration of bacteria bound ± the standard deviation (in RT-qPCRU) (bars) and percent binding efficiency as determined by loss-to-supernatant ((total input virus-supernatant virus)/total input virus) (numerical). Letters indicate statistically significant differences (p<0.05) between the amount of virus bound for each bacterial strain cultured using different growth media. Different letters within the same bacteria indicate statistical difference. Statistical differences in binding between different bacteria was not tested. Data represent averages and standard deviations of the assays performed in triplicate.</p

    Bacterial strains and growth media used in this study.

    No full text
    <p>Bacterial strains and growth media used in this study.</p
    corecore